Lymphocyte-Related Immunomodulatory Therapy with Siponimod (BAF-312) Improves Outcomes in Mice with Acute Intracerebral Hemorrhage.

MLA

Zhiying Zhang, et al. “Lymphocyte-Related Immunomodulatory Therapy with Siponimod (BAF-312) Improves Outcomes in Mice with Acute Intracerebral Hemorrhage.” Aging & Disease, vol. 14, no. 3, June 2023, pp. 966–91. EBSCOhost, https://doi.org/10.14336/AD.2022.1102.

APA

Zhiying Zhang, Yinuo Li, Juyuan Shi, Li Zhu, Yinming Dai, Peiji Fu, Simon Liu, Michael Hong, Jiewen Zhang, Jian Wang, & Chao Jiang. (2023). Lymphocyte-Related Immunomodulatory Therapy with Siponimod (BAF-312) Improves Outcomes in Mice with Acute Intracerebral Hemorrhage. Aging & Disease, 14(3), 966–991. https://doi.org/10.14336/AD.2022.1102

Chicago

Zhiying Zhang, Yinuo Li, Juyuan Shi, Li Zhu, Yinming Dai, Peiji Fu, Simon Liu, et al. 2023. “Lymphocyte-Related Immunomodulatory Therapy with Siponimod (BAF-312) Improves Outcomes in Mice with Acute Intracerebral Hemorrhage.” Aging & Disease 14 (3): 966–91. doi:10.14336/AD.2022.1102.